By
Drug Target Review2025-02-21T09:00:18
A new UCLA study reveals that DNA mismatch repair genes play a crucial role in Huntington’s disease by driving neuronal damage and motor impairments. Targeting these genes, especially Msh3 and Pms1, could offer promising therapeutic avenues for the disease.
Already a member? Sign in
By highlighting cutting-edge research and its practical applications, Drug Target Review enables readers to make decisions that accelerate innovation, translate discoveries into therapies, and create tangible benefits for patients worldwide.
By becoming a member you join a connected and collaborative community driving the industry forward. Member benefits include:
2026-05-12T09:31:00Z
Contributor Sugish Pillai, Axel Ziemke and Dr Gary Kusdian
2026-05-11T12:59:00Z
2024-01-24T12:52:38
Sponsored by BellBrook Labs
2023-02-02T11:05:15
Sponsored by Cell Signaling Technology
2023-01-06T10:25:33
Sponsored by Leica Microsystems
2025-08-05T13:42:00
Sponsored by ICON plc., By Drug Target Review
2024-05-07T13:11:19
Sponsored by BellBrook Labs
2023-04-12T15:28:08
Sponsored by nanoComposix
Site powered by Webvision Cloud